Evaluation of granulocyte-colony stimulating factor (Filgrastim) in infected diabetic foot ulcers

Diabetologia

Volumn 46, Issue 1, 2003, Pages 27-30

  Kastenbauer T ^a   Hornlein B ^a   Sokol, G ^a   Irsigler, K ^a  

^a GENERAL HOSPITAL LINZ   (Austria)

Author keywords

Clinical trial; Diabetes; Foot ulceration; Granulocyte colony stimulating factor; Infection

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; CLINDAMYCIN; PLACEBO; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; ARTICLE; BED REST; CELLULITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEBRIDEMENT; DIABETIC FOOT; DRUG EFFICACY; EVALUATION; FEMALE; HOSPITALIZATION; HUMAN; LIVER FUNCTION TEST; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SIDE EFFECT; SINGLE BLIND PROCEDURE; SKIN DISEASE; SKIN EFFLORESCENCE; STATISTICAL ANALYSIS; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0037287004     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-002-0998-z     Document Type: Article

References (8)

1. Marboffer W, Stein M, Maeser E, Ferderlin K (1992) Impairment of polymorphonuclear leukocyte function and metabolic control in diabetes. Diabetes Care 15: 256-260
2. Sato N, Shimizu H, Suwa K, Shimomura Y, Kobayashi I, Mori M (1992) MPO activity and generation of active O2 species in leukocytes from poorly controlled diabetic patients. Diabetes Care 15: 1050-1052
3. West NJ (1995) Systemic antimicrobial treatment of foot infections in diabetic patients. Am J Health Syst Pharm 52: 1199-2007
4. Sato N, Kashima K, Tanaka Y, Shimizu H, Mori M (1997) Effect of granulocyte-colony stimulating factor on generation of oxygen-derived free radicals and myeloperoxidase activity in neutrophils from poorly controlled NIDDM patients. Diabetes 46: 133-137
5. Gough A, Clapperton M, Rolando N, Foster AVM, Philpott-Howard J, Edmonds E (1997) Randomised placebo-controlled trial of granulocyte-colony stimulating factor in diabetic foot infection. Lancet 350: 855-859
6. Yönem A, Cakir B, Güler S, Azal Ö, Corakci A (2001) Effects of granulocyte-colony stimulating factor in the treatment of diabetic foot infection. Diabetes Obes Metab 3: 332-337
7. Wagner FW (1981) The dysvascular foot: a system for diagnosis and treatment. Foot Ankle 2: 64-122
8. Cavanagh PR, Ulbrecht JS, Caputo GM (2000) New developments in the biomechanics of the diabetic foot. Diabetes Metab Res Rev 16 [Suppl 1]: S6-S10